Charles A Rowland Jr Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Charles A Rowland Jr.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Charles A Rowland Jr. Charles A Rowland Jr is a EVP, CFO & Treasurer in ENDO HEALTH SOLUTIONS INC. ($ENDP) and a Director in Vitae Pharmaceuticals, Inc ($VTAE) and a Director in BIND Therapeutics, Inc ($BIND) and a Director in Blueprint Medicines Corp ($BPMC) and a Director in Viking Therapeutics, Inc. ($VKTX) and a Director in Nabriva Therapeutics plc ($NBRV) and a Director in Nabriva Therapeutics Plc ($NBRV) and a in Generation Bio Co. ($GBIO) and a Director in Generation Bio Co. ($GBIO) and a Director in Orchard Therapeutics plc ($ORTX).
Address: 100 ENDO BOULEVARD CHADDS FORD 19317 PA
Companies in which Charles A Rowland Jr is an Insider
Blueprint Medicines Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Charles A Rowland Jr: Director
Holdings: 14,471 shares
Current Value: $518,641
Latest Transaction: Dec 18 2020
$BPMC Market Capitalization: $979.55M
$BPMC Previous Close: $35.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DNIB UNWIND, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Charles A Rowland Jr: Director
Holdings: 15,000 shares
Latest Transaction: Aug 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ENDO HEALTH SOLUTIONS INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Charles A Rowland Jr: EVP, CFO & Treasurer
Holdings: 6,699 shares
Current Value: $80,455
Latest Transaction: Feb 25 2008
$ENDP Market Capitalization: $2.74B
$ENDP Previous Close: $12.01
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Generation Bio Co.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Charles A Rowland Jr:
Holdings: 101,035 shares
Latest Transaction: Jan 13 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nabriva Therapeutics Legacy plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Charles A Rowland Jr: Director
Holdings: 0 shares
Latest Transaction: Jun 27 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nabriva Therapeutics plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Charles A Rowland Jr: Director
Holdings: 70,500 shares
Current Value: $570,345
Latest Transaction: Jul 31 2020
$NBRV Market Capitalization: $180.88M
$NBRV Previous Close: $8.09
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Orchard Therapeutics plc
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Charles A Rowland Jr: Director
Holdings: 0 shares
Latest Transaction: Jun 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Viking Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Charles A Rowland Jr: Director
Holdings: 30,000 shares
Current Value: $43,500
Latest Transaction: Jan 06 2021
$VKTX Market Capitalization: $31.36M
$VKTX Previous Close: $1.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vitae Pharmaceuticals, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Charles A Rowland Jr: Director
Holdings: 0 shares
Latest Transaction: Oct 25 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Charles A Rowland Jr
Sentiment: All, BPMC, BIND, ENDP, GBIO, NBRV, NBRV, ORTX, VKTX, VTAE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13 2021 | GBIO | Generation Bio Co. | Rowland Charles A Jr | Buy | P | 24.50 | 20,408 | 499,996 | 101,035 | 80.6 K to 101 K (+25.31 %) | |
| Jan 06 2021 | VKTX | Viking Therapeutic ... | Rowland Charles A Jr | Director | Option Exercise | A | 5.80 | 22,000 | 127,600 | 22,000 | |
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 19.53 | 10,909 | 213,053 | 0 | |
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 117.82 | 10,909 | 1,285,298 | 3,562 | 14.5 K to 3.6 K (-75.39 %) |
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 19.53 | 10,909 | 213,053 | 14,471 | 3.6 K to 14.5 K (+306.26 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 9.46 | 5,522 | 52,238 | 0 | |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 9.46 | 4,478 | 42,362 | 5,522 |